From early clinical development through late phase trials, with the flexibility to adapt as your program evolves.
Looking for a CRO that can provide you with:
Look no further than Worldwide Clinical Trials.
We’ll connect you with the right oncology clinical
development team.
Partnership, expertise, guidance, and execution you can rely on.
Our teams are aligned by indication, bringing scientific depth and regulatory insight that supports trial design, site strategy, and execution, without forcing sponsors to educate their CRO along the way.
Sponsors work with stable, experienced teams who remain accountable as trials progress, helping reduce risk, preserve context, and maintain operational continuity.
From full‑service trial management to functional partnerships through Worldwide Flex, our engagement models adapt to your needs rather than forcing a one‑size‑fits‑all approach.
From enrollment to execution, experienced teams and therapeutic expertise drive consistent, reliable results.
Projects Completed
Countries
Indications
Sites
Patients Enrolled
Worldwide consistently enrolls studies on time, or faster, by pairing strategic site selection with proactive patient engagement.
From ultra‑rare pediatric trials to global Phase III programs, Worldwide has delivered results where speed, sensitivity, and precision matter most.
Sponsors work with stable project teams from kickoff to close‑out, supporting continuity, faster decision‑making, and stronger site relationships.
Dedicated teams who know your indication and your challenges.
From early development through global Phase III registration trials and beyond.
That’s why we’re focused on addressing your questions from the start.
We emphasize transparency and proactive communication throughout the trial life cycle. At Worldwide, you work with experienced project leaders and consistent teams who provide clear reporting, regular touchpoints, and early escalation, so issues are visible, understood, and addressed before they become risks.
Meeting timelines requires more than aggressive targets. Worldwide’s therapeutically aligned teams and experienced project managers apply structured planning, ongoing oversight, and early issue escalation to help sponsors maintain momentum and adapt when challenges arise, protecting timelines without sacrificing quality.
Senior operational and scientific leaders remain engaged throughout your trial, not just during kickoff, so decisions stay informed and responsive.
Worldwide is organized by therapeutic area, with dedicated teams who bring indication‑specific expertise across trial design, patient populations, site strategy, regulatory pathways, and execution, so complexity is addressed proactively, not reactively.
Your experience is important to us.
We understand that different sponsors have different priorities
Lean teams. High stakes. No margin for missteps. Emerging biotechs need a CRO that brings senior‑level expertise, practical guidance, and accountability from day one. Worldwide provides direct access to experienced leaders, flexible engagement models, and therapeutically focused teams that help supplement limited internal resources and navigate complexity with confidence.
Complex portfolios. Competing priorities. The need for consistency across programs and regions. Worldwide partners with established pharma organizations to deliver reliable execution at scale, bringing therapeutic specialization, experienced project leadership, and governance models that support alignment across global studies without sacrificing quality or visibility.
Not just speed or scale, but the right partner. Specialty and mid‑size pharma companies turn to Worldwide when they want a CRO that operates as a strategic extension of their team. We combine the focus and expertise of a specialist with the global reach and operational strength needed to support programs across phases and geographies.
The experts you meet at the bid defense are the experts who will run your trial, from first patient in to database lock.
Chief Medical and Scientific Officer
Former FDA reviewer with 15+ years in gene therapy development. Deep expertise in regulatory pathways.
Chief Therapeutics & Clinical Strategy Officer and President of Europe
Biotech leader with 35+ years’ experience, advancing therapies, driving innovation, commercialization, and growth.
Chief Development Officer
Neuroscience development leader with 30 years’ experience, advancing CNS trials, data quality, regulatory strategy, and innovation.
At Worldwide Clinical Trials, we deliver high-quality, reliable, and timely clinical trial services to help optimize the success of your projects. For the second year in a row, data from the Industry Standard Research (ISR) report showed that Worldwide Clinical Trials was the highest-rated Phase II/III CRO across several categories.